Propionate raises insulin-opposing hormones in humans
A randomised, placebo-controlled crossover study gave 28 healthy volunteers a dose of calcium propionate comparable to a typical commercial bread serving and measured hormone levels. Propionate significantly raised glucagon, norepinephrine, and fatty acid binding protein 4 (FABP4), all of which oppose the action of insulin. The same study found parallel effects in mice, including elevated glucose production by the liver. A follow-up study in 2021 found acute impairment of glucose metabolism in humans at dietary exposure levels. Researchers described it as a potential metabolic disruptor.
Propionate at doses comparable to a typical preserved-bread serving raised glucagon, norepinephrine, and FABP4 in healthy humans in a randomised controlled trial, increasing endogenous glucose production in a pattern consistent with insulin resistance.
2019RCTTirosh et al., Science Translational Medicine
A follow-up human study found that acute ingestion of propionic acid at food-additive exposure levels impaired glucose metabolism, adding to concerns about chronic dietary exposure in populations eating preserved bread daily.
2021RCTBMJ Open Diabetes Research and Care
Mouse studies alongside the human RCT showed that chronic propionate exposure led to weight gain, hyperinsulinemia, and insulin resistance, prompting calls for the FDA and food regulators to re-examine the additive.
2019RCTTirosh et al., Science Translational Medicine
EFSA re-evaluation: no genotoxicity, ADI set
The European Food Safety Authority completed a full re-evaluation of propionic acid and the propionate salts in 2014. EFSA found no evidence of genotoxicity or carcinogenicity and established an acceptable daily intake of 3mg per kilogram of body weight per day. The panel noted that typical food exposures fall within this limit for most consumer groups, though high bread consumers may approach it. The 2019 and 2021 human metabolic studies post-date this evaluation and have not yet been incorporated into a formal EFSA or UK FSA regulatory review.
EFSA's re-evaluation found no genotoxic or carcinogenic concern and established an ADI of 3mg per kg body weight per day for propionic acid and its salts combined.
2014Regulatory reviewEFSA Panel on Food Additives and Nutrient Sources (ANS), EFSA Journal
High-level bread consumers, including some children, may have dietary exposures to propionates approaching the ADI when total intake from all sources is combined.
2014Regulatory reviewEFSA Panel on Food Additives and Nutrient Sources (ANS), EFSA Journal
Autism research: propionate as a gut-brain signal
Some researchers have investigated propionate as a gut-derived neuroactive compound, noting that it is produced in large quantities by certain gut bacteria and can cross into the bloodstream and brain. Animal studies have shown that injecting large doses of propionate into rat brains produces repetitive behaviours resembling autism. These are high-dose injection studies, not dietary exposure studies, and the link to dietary propionate from food additives in humans remains speculative and unestablished.
Infusion of propionate directly into rat brains induced repetitive motor behaviours and social deficits in high-dose animal studies, leading some researchers to hypothesise a gut-brain propionate pathway relevant to autism. These findings do not apply directly to oral food-additive exposure.
2007AnimalMacFabe et al., Behavioural Brain Research